Intestinal Non-Hodgkin Lymphoma — Trials

Intestinal Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

29 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03075553	Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma	terminated	Phase 2	12	Mayo ClinicOTHER	1	Apr 21, 2020	clinicaltrials

Data updated 22 days agoSource updated Apr 21, 2020source: clinicaltrials